Bacterial infections such as chlamydia, gonorrhoea and syphilis can be treated and cured with antibiotics. Antiviral drugs can be used to treat some viral infections.

Sexually transmitted infections tests and treatment: latest news

Sexually transmitted infections tests and treatment resources

  • NGU and NSU – non-gonococcal and non-specific urethritis

    NGU and NSU can be caused by several STIs.NGU/NSU is diagnosed by a swab test and/or checking a urine sample.NGU and NSU are treated with...

    From: Factsheets

    Information level Level 2
  • Herpes

    Herpes is transmitted by contact with skin where the herpes simplex virus is present. It causes painful blisters on the genital and surrounding areas.Antiviral treatments...

    From: Factsheets

    Information level Level 2
  • Shigella

    Shigella is a serious gut infection causing severe, prolonged diarrhoea and stomach cramps. It is transmitted by contact with very small amounts of human faeces....

    From: Factsheets

    Information level Level 2
  • Pubic lice and scabies

    Pubic lice and scabies are easily treated.Your GP or staff at a sexual health clinic can diagnose pubic lice or scabies.Pubic lice and scabies are...

    From: Factsheets

    Information level Level 2
  • LGV (lymphogranuloma venereum)

    LGV is a form of chlamydia. Tests for chlamydia also detect LGV.Most LGV cases are in gay men living with HIV. It is often diagnosed...

    From: Factsheets

    Information level Level 2
  • Chlamydia

    Chlamydia can be transmitted via infected semen or vaginal fluids.Using a condom during sex is an effective way of preventing  chlamydia.Chlamydia is easily treated with...

    From: Factsheets

    Information level Level 2
  • Gonorrhoea

    Gonorrhoea can be passed on during anal, vaginal and oral sex.Using a condom during sex is an effective way of preventing gonorrhoea.Gonorrhoea is treated with...

    From: Factsheets

    Information level Level 2
  • Human papillomavirus (HPV) and genital warts

    HPV can be passed on during unprotected anal, vaginal or oral sex. Vaccines against HPV are available.  Some strains of HPV can cause genital warts....

    From: Factsheets

    Information level Level 2
  • Syphilis

    Syphilis is a common sexually transmitted infection that is usually easy to treat.Syphilis can progress more quickly and severely in people living with HIV.It can be contracted during...

    From: Factsheets

    Information level Level 2
  • Sexually transmitted infections

    This section contains a brief explanation of how common sexually transmitted infections (STIs) are passed on, their symptoms and their treatment. STIs can be caused by bacteria, viruses...

    From: Booklets

    Information level Level 2
  • Treating sexually transmitted infections to prevent HIV

    One strand of investigation in the biomedical prevention of HIV is to see whether we can reduce HIV incidence by treating other sexually transmitted infections...

    From: Preventing HIV

    Information level Level 4

Sexually transmitted infections tests and treatment news from aidsmap

  • How dangerous is gonorrhoea resistance and can it be halted?

    The bacterium that causes the common sexually transmitted infection (STI) gonorrhoea develops resistance to antibiotics easily, and some cases of multidrug-resistant gonorrhoea, originating from abroad, were reported from the UK this year, raising concerns that gonorrhoea could become untreatable. ...

    06 December 2018 | Gus Cairns
  • Drug-resistant gonorrhoea rates plummet in US

    Preliminary results announced at the US 2014 STD Prevention Conference in Atlanta have shown that the proportion of cases of gonorrhoea that are drug-resistant has fallen since 2011, with a sharp decline between 2012 and 2013. The fall is particularly ...

    16 June 2014 | Gus Cairns
  • HIV infection doesn't generally affect the response to syphilis treatment

    Well-controlled HIV infection does not have a significant impact on the serological response to treatment for syphilis, Swiss investigators report in the online edition of Clinical Infectious Diseases. However, they found that syphilis stage was a significant factor in ...

    18 September 2012 | Michael Carter
  • Reduced susceptibility to first-line drug causes change in UK gonorrhoea prescribing practice

    UK Prescribing guidance for the treatment of gonorrhoea needs to change because of increasing prevalence of bacteria with reduced susceptibility to the first-line antibiotic cefixime, the Health Protection Agency (HPA) has announced.  Some 17% of gonorrhoea samples tested ...

    11 October 2011 | Michael Carter
  • Herpes drugs and viral load: valaciclovir works better than aciclovir

    The anti-herpes drug valaciclovir (Valtrex, valacyclovir in the US) produced a 17-fold (1.23 log) reduction in HIV viral load in Kenyan patients not taking treatment, the sixth International AIDS Society conference (IAS 2011) in Rome heard last Wednesday. Last Monday, ...

    26 July 2011 | Gus Cairns
  • Daily aciclovir slows HIV disease progression and reduces viral load

    Daily treatment with standard-dose aciclovir delays HIV disease progression and lowers viral load in patients co-infected with herpes simplex virus-2 (HSV-2), results of a study presented to the Sixth International AIDS Conference (IAS 2011) in Rome show. Two more ...

    19 July 2011 | Michael Carter
  • Guidelines for treatment of syphilis in patients with HIV have very poor evidence base

    Current guidelines for the treatment of syphilis in patients with HIV are based on limited clinical data, investigators show in the online edition of Sexually Transmitted Infections. Even though their systematic review had broad inclusion criteria, they were only able ...

    21 October 2010 | Michael Carter
  • One in ten people in UK with gonorrhoea have a strain with reduced susceptibility to treatment

    Depending of the definition of ‘resistance’ used, between 1% and 10% of people with gonorrhoea in the UK have a strain which is resistant to the antibiotic that is most frequently used to treat the infection. Releasing the data ...

    25 August 2010 | Roger Pebody
  • Popular opinion leaders add no benefit to intensive HIV prevention

    HIV prevention using ‘popular opinion leaders’ is no more effective at reducing risky sexual behaviour and the incidence of sexually transmitted infections than prevention consisting of counselling, treating sexually transmitted infections, and condom provision, investigators report ...

    07 April 2010 | Michael Carter
  • Aciclovir shows lower efficacy outside US in global trial

    Aciclovir’s efficacy in preventing genital ulcers and lowering herpes simplex virus-2 load varied significantly between the US and resource poor countries, investigators from a large international clinical trial report in the April 15th edition of the ...

    19 March 2010 | Michael Carter
More news

Sexually transmitted infections tests and treatment news selected from other sources

  • FDA Approves First Throat and Rectal Tests for Detecting Chlamydia and Gonorrhea

    The U.S. Food and Drug Administration (FDA) announced on May 23 that it had cleared the Aptima Combo 2 Assay and Xpert CT/NG to detect chlamydia and gonorrhea by using throat and rectum samples, potentially making it easier for physicians and public health programs to diagnose and treat sexually transmitted infections (STIs) that are often undertreated for lack of testing in those areas.

    02 June 2019 | The Body Pro
  • Drug combination could be effective for treatment-resistant gonorrhea

    Scientists comparing treatments for gonorrhea have identified a drug combination that could be an effective back-up for patients not responding to current therapy. The research team, from University Hospitals Birmingham, found that a treatment of the antibiotic gentamicin with azithromycin worked almost as well as the currently used ceftriaxone for genital gonorrhea.

    07 May 2019 | Eurekalert Inf Dis
  • Pipeline for Gonorrhea, Chlamydia, and Syphilis

    A new report on the sexually transmitted infection (STI) treatment and prevention research “pipeline” points to serious gaps in the development of new tools to address a growing epidemic in the U.S. The report, released today by Treatment Action Group (TAG), provides an assessment of the current research pipeline and calls for a major new investment in STI research.

    20 March 2019 | TAG
  • Sex clinics show how competition can improve England’s NHS

    Patients can walk into clinics without a referral, so providers have to compete for their business.

    15 March 2019 | The Economist (requires free registration)
  • Illegal STI drugs being sold online

    Unlicensed antibiotics are being advertised on social media as treatment for sexually transmitted infections and sold at the wrong dose.

    04 March 2019 | BBC Health
  • Gonorrhoea: drug resistance compromises recommended treatment in Europe

    In 2017, 27 EU/EEA countries collected and tested 3 248 gonococcal isolates which revealed that cefixime and azithromycin resistance (1.9% and 7.5% respectively) remained unchanged compared to 2016 (2.1% and 7.5%). However, the number of countries reporting resistant isolates for each antimicrobial increased. For the second year in a row, no isolates with resistance to ceftriaxone were detected in contrast to one in 2015, five in 2014 and seven in 2013.

    28 February 2019 | ECDC
  • UK Gonorrhea Guideline Guards Against Antibiotic Resistance

    A new guideline on the management of gonorrhea has been issued by the British Association for Sexual Health and HIV. The 2019 guideline introduced changes made to the 2011 guideline including: removing the recommendation for dual therapy with azithromycin, increasing the dose of ceftriaxone, recommending the use of ciprofloxacin in certain cases, and adding extra-genital testing in cases of known or suspected antimicrobial resistance.

    30 January 2019 | MD Magazine
  • This Is What It’s Like To Lose Your Local Sexual Health Clinic Under Austerity

    In a new series, HuffPost UK is examining how shrinking local budgets are affecting people’s daily lives. These are stories of what it’s like to lose, in a society that is quietly changing.

    23 January 2019 | Huffington Post
  • Testing times: four emerging STIs that you can’t afford to ignore

    Although gonorrhoea, chlamydia and syphilis grab most of the headlines, public health officials are warily watching the emergence of other bacterial sexually transmitted infections.

    06 December 2018 | Mosaic
  • Drug-resistance of gonorrhoea in the EU: persistent but stable

    Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

    04 September 2018 | ECDC
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.